BridgeBio Pharma secures $299m in funding to accelerate genetic disease drug development

BridgeBio Pharma, a leading clinical-stage biopharma company specialising in treatments for genetic diseases, has raised $299.2 million in a new funding round. The California-based firm ... Read More